Anti‐TNFα induced lupus due to infliximab therapy in a patient with concurrent Crohn's disease

Anti‐TNFα inhibitor‐induced Lupus (ATIL) is a rare syndrome characterized by a wide array of symptoms ranging from skin manifestations to organ‐specific symptoms such as pleural effusions, pericardial effusions, hepatotoxicity, etc. Infliximab is implicated in most cases, and ATIL usually develops b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Akanksha, Ahmed, Taha, Mehta, Aashna, Birnbaum, Julius, Shrestha, Abhigan Babu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354357/
https://www.ncbi.nlm.nih.gov/pubmed/37476595
http://dx.doi.org/10.1002/ccr3.7673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354357/
https://www.ncbi.nlm.nih.gov/pubmed/37476595
http://dx.doi.org/10.1002/ccr3.7673

Ejemplares similares